Raymond James Financial Services Advisors’s Allergan plc AGN.PRA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-674	Closed	-$395K	–	2815
2017 Q4	$395K	Buy	674 +39	+6%	+$25.2K	﹤0.01%	1844
2017 Q3	$469K	Sell	635 -12	-2%	-$9.96K	﹤0.01%	1753
2017 Q2	$561K	Buy	647 +8	+1%	+$6.7K	﹤0.01%	1616
2017 Q1	$542K	Sell	639 -20	-3%	-$16.6K	﹤0.01%	1517
2016 Q4	$502K	Sell	659 -44	-6%	-$33.3K	﹤0.01%	1517
2016 Q3	$578K	Buy	703 +89	+14%	+$76.9K	0.01%	1422
2016 Q2	$512K	Buy	614 +179	+41%	+$150K	0.01%	1412
2016 Q1	$400K	Buy	+435	New	+$416K	﹤0.01%	1377

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Raymond James Financial Services Advisors's AGN.PRA Position: Q1 2018 in Review

Raymond James Financial Services Advisors sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 674 shares — an estimated $395K sold.

Raymond James Financial Services Advisors first reported a position in AGN.PRA in Q1 2016 and held it in 8 quarters. The position peaked at $578K in Q3 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Raymond James Financial Services Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Raymond James Financial Services Advisors sold 674 Allergan plc shares in Q1 2018, an estimated $395K.
Raymond James Financial Services Advisors first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
Raymond James Financial Services Advisors's Allergan plc position peaked at $578K in Q3 2016.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2018, filed 16 Apr 2018.